Catch-up on critical information – on your own time.
The 7th Annual Forum on Pathways to Access & Reimbursement took place on January 20-21, 2022. Our outstanding faculty share insights on the most compelling topics impacting their daily lives and practices. See a snapshot of the event below then purchase the recording to watch at your convenience.
2022 Conference Co-Chairs
Alexis Sciuk
Canadian Health Care Solutions Lead
Pfizer
Farah Husein
Director, Evidence Generation
Scientific and Medical Affairs, Takeda Canada
2022 FEATURED SPEAKERS
Dr. Mark Chilvers
Pediatric Respirologist, BCCH CF Clinic Director, Medical Director
CF Care BC
Sang Mi Lee
Access Lead, Personalized Healthcare
Roche
Brad Groves
Associate Director, Managed Access
NICE.
2022 CONFERENCE HIGHLIGHTS
- The impact of the pandemic on CADTH reviews and pCPA negotiations, and how to mitigate time-to-market delays
- Cell and Gene Therapy: How to secure public/private payer reimbursement for these potentially life-changing but high-cost therapies
- How to attract and retain top-notch talent to Canada’s life sciences sector amid shifting public policy
- Data and AI: How to obtain, analyze, and utilize health outcome data to empower decision-making from clinical trials to reimbursement and beyond
Conference Program
View the Complete Agenda and Speakers List